These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35533885)

  • 21. Psychosocial interventions for supporting women to stop smoking in pregnancy.
    Chamberlain C; O'Mara-Eves A; Porter J; Coleman T; Perlen SM; Thomas J; McKenzie JE
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001055. PubMed ID: 28196405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incentives and Patches for Medicaid Smokers: An RCT.
    Anderson CM; Cummins SE; Kohatsu ND; Gamst AC; Zhu SH
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S138-S147. PubMed ID: 30454668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Financial Incentives Alone Versus Incentivized Partner Support for Promoting Smoking Cessation During Pregnancy and Postpartum: Protocol for a Non-Randomized Single-Blinded Study.
    Frandsen M; Thow M; Ferguson SG
    JMIR Res Protoc; 2017 Oct; 6(10):e209. PubMed ID: 29089293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A protocol for the economic evaluation of the smoking Cessation in Pregnancy Incentives Trial III (CPIT III).
    McMeekin N; Sinclair L; Bauld L; Tappin DM; Mitchell A; Boyd KA
    BMJ Open; 2020 Oct; 10(10):e038827. PubMed ID: 33109658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.
    Pandya A; Asch DA; Volpp KG; Sy S; Troxel AB; Zhu J; Weinstein MC; Rosenthal MB; Gaziano TA
    JAMA Netw Open; 2018 Sep; 1(5):e182008. PubMed ID: 30646152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
    Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
    Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare financing systems for increasing the use of tobacco dependence treatment.
    van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial.
    Tappin D; Sinclair L; Kee F; McFadden M; Robinson-Smith L; Mitchell A; Keding A; Watson J; Watson S; Dick A; Torgerson D; Hewitt C; McKell J; Hoddinott P; Harris FM; Boyd KA; McMeekin N; Ussher M; Bauld L
    BMJ; 2022 Oct; 379():e071522. PubMed ID: 36261162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Financial Incentives for Smoking Cessation on Mood and Anxiety Symptoms Among Pregnant and Newly Postpartum Women.
    Zvorsky I; Skelly JM; Higgins ST
    Nicotine Tob Res; 2018 Apr; 20(5):620-627. PubMed ID: 28531302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model.
    Jones M; Smith M; Lewis S; Parrott S; Coleman T
    Addiction; 2022 Nov; 117(11):2907-2917. PubMed ID: 35661312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smartphone-based financial incentives to promote smoking cessation during pregnancy: A pilot study.
    Kurti AN; Tang K; Bolivar HA; Evemy C; Medina N; Skelly J; Nighbor T; Higgins ST
    Prev Med; 2020 Nov; 140():106201. PubMed ID: 32652133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining two different schedules of financial incentives for smoking cessation among pregnant women.
    Higgins ST; Washio Y; Lopez AA; Heil SH; Solomon LJ; Lynch ME; Hanson JD; Higgins TM; Skelly JM; Redner R; Bernstein IM
    Prev Med; 2014 Nov; 68():51-7. PubMed ID: 24704135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.
    Mundt MP; Baker TB; Piper ME; Smith SS; Fraser DL; Fiore MC
    Tob Control; 2020 May; 29(3):320-325. PubMed ID: 31147478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
    Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
    Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial incentives for smoking cessation among pregnant and newly postpartum women.
    Higgins ST; Washio Y; Heil SH; Solomon LJ; Gaalema DE; Higgins TM; Bernstein IM
    Prev Med; 2012 Nov; 55 Suppl(Suppl):S33-40. PubMed ID: 22227223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
    Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic Evaluation of Enhanced vs Standard Varenicline Treatment for Tobacco Cessation.
    Mundt MP; Stein JH; Fiore MC; Baker TB
    JAMA Netw Open; 2024 Apr; 7(4):e248727. PubMed ID: 38683609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.